Stephen Ansell, MD, PhD, reviews practice-changing data and expert recommendations for treating patients with mantle cell lymphoma (MCL).
Expert slideset reviewing how to optimize ALL treatment and manage CRS and neurologic adverse events with BiTE constructs and CAR T-cell therapies.
Immunotherapies in B-cell ALL: Get up to date on how BiTE constructs and CAR T-cells are improving response rates in this challenging malignancy.
In this downloadable slideset from the MRD in ALL video, Elias Jabbour, MD, Joseph D. Khoury, MD, and Aaron C. Logan, MD, PhD, provide expert perspective on incorporating MRD testing in ALL and the use of blinatumomab in MRD-positive ALL after CR to provide your patients with better outcomes.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.